Patents by Inventor Nada PODZIMKOVA

Nada PODZIMKOVA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING NON-MELANOMA SKIN CANCER
    Publication number: 20230398185
    Abstract: The present invention relates to an interleukin-2/interleukin-15 receptor ?? (IL-2/IL-15R??) agonist for use in the treatment of non-melanoma skin cancer. Further provided are dosing schemes for treating patients with non-melanoma skin cancer with an IL-2/IL-15R?? agonist.
    Type: Application
    Filed: October 26, 2021
    Publication date: December 14, 2023
    Inventors: Stefano FERRARA, Ulrich MOEBIUS, David BÉCHARD, Irena ADKINS, Nada PODZIMKOVA
  • IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING SQUAMOUS CELL CARCINOMA
    Publication number: 20230390361
    Abstract: The present invention relates to an interleutkin-2/interleutkin-15 receptor ?? (IL-2/IL-15R??) agonist for use in the treatment of squamous cell carcinoma. Further provided are dosing schemes for treating patients with squamous cell carcinoma with an IL-2/IL-15R?? agonist.
    Type: Application
    Filed: October 26, 2021
    Publication date: December 7, 2023
    Inventors: Stefano FERRARA, Ulrich MOEBIUS, David BÉCHARD, Irena ADKINS, Nada PODZIMKOVA
  • IL-2/IL-15R BETA GAMMA AGONIST DOSING REGIMENS FOR TREATING CANCER OR INFECTIOUS DISEASES
    Publication number: 20220241375
    Abstract: The present invention provides pulsed cyclic administration regimes and pulsed administration regimes for interleukin-2/interleukin-15 receptor ?? (IL-2/IL-15R??) agonists for treating or managing cancer or infectious diseases in human patients. The administration regimes inter alia involve daily administration of IL-2/IL-15R?? agonists on 2, 3 or 4 consecutive days followed by days without administration.
    Type: Application
    Filed: May 20, 2020
    Publication date: August 4, 2022
    Inventors: Ulrich MOEBIUS, David BECHARD, Irena ADKINS, Nada PODZIMKOVA
  • IMMUNOTHERAPY FOR CANCER
    Publication number: 20210252120
    Abstract: Disclosed is a composition comprising an immunogenic composition for use in treatment of squamous cell carcinoma in combination with myeloid-derived suppressor cell-inhibiting agents as well as a corresponding method of treatment.
    Type: Application
    Filed: January 4, 2021
    Publication date: August 19, 2021
    Inventors: Irena ADKINS, Nada PODZIMKOVÁ, Ondrej PALATA, Radek SPISEK